Back
ArriVent BioPharma, Inc. AVBP · Insights
ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the identification,... Price14.16
Market Cap698.2 M
Float37 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro